SOST and hyperphosphatemia: In animals with high PTH levels, the efficacy of anti-sclerostin antibody was compromised, likely due to PTH suppressing SOST (sclerostin gene) expression (Cejka et al., 2011), interference with Wnt receptor, or the effects of hyperphosphatemia and increased FGF23.